Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Orchard Therapeutics Plc (ORTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Orchard Therapeutics Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1748907.
Total stock buying since 2020: $3,577,734.
Total stock sales since 2020: $14,725,461.
Total stock option exercises since 2020: $67,160.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 0 | $0 | 40,000 | $18,360 |
| 2022 | 25,000 | $18,555 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 2,045,510 | $14,277,659 | 10,000 | $24,400 |
| 2020 | 769,017 | $3,559,179 | 33,395 | $447,802 | 14,921 | $24,400 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 0 | $0 | 0 | $0 | 20,000 | $9,180 |
| 2023-02 | 0 | $0 | 0 | $0 | 20,000 | $9,180 |
| 2022-04 | 25,000 | $18,555 | 0 | $0 | 0 | $0 |
| 2021-02 | 0 | $0 | 2,045,510 | $14,277,659 | 0 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 10,000 | $24,400 |
| 2020-09 | 473,327 | $2,182,037 | 0 | $0 | 0 | $0 |
| 2020-08 | 295,690 | $1,377,142 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 0 | $0 | 10,000 | $24,400 |
| 2020-03 | 0 | $0 | 4,921 | $63,973 | 4,921 | $0 |
| 2020-01 | 0 | $0 | 28,474 | $383,829 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-10 | Thomas Frank E (See Remarks) | Option Ex | 20,000 | .46 | 9,180 |
| 2023-02-09 | Thomas Frank E (See Remarks) | Option Ex | 20,000 | .46 | 9,180 |
| 2022-04-01 | Gaspar Bobby (Chief Executive Officer) | Buy | 15,000 | .74 | 11,085 |
| 2022-04-01 | Thomas Frank E (See Remarks) | Buy | 10,000 | .75 | 7,470 |
| 2021-02-05 | Fmr Llc (Other) | Sale | 2,045,510 | 6.98 | 14,277,659 |
| 2021-01-29 | Thomas Frank E (See Remarks) | Option Ex | 10,000 | 2.44 | 24,400 |
| 2020-09-24 | Shah Rajeev M. | Buy | 473,327 | 4.61 | 2,182,037 |
| 2020-08-21 | Shah Rajeev M. | Buy | 64,642 | 4.58 | 295,737 |
| 2020-08-20 | Shah Rajeev M. | Buy | 62,631 | 4.61 | 288,728 |
| 2020-08-19 | Shah Rajeev M. | Buy | 64,254 | 4.67 | 300,066 |
| 2020-08-18 | Shah Rajeev M. | Buy | 45,249 | 4.72 | 213,575 |
| 2020-08-17 | Shah Rajeev M. | Buy | 8,235 | 4.74 | 39,033 |
| 2020-08-14 | Shah Rajeev M. | Buy | 13,031 | 4.74 | 61,766 |
| 2020-08-12 | Shah Rajeev M. | Buy | 16,291 | 4.74 | 77,219 |
| 2020-08-10 | Shah Rajeev M. | Buy | 21,357 | 4.73 | 101,018 |
| 2020-06-11 | Thomas Frank E (See Remarks) | Option Ex | 10,000 | 2.44 | 24,400 |
| 2020-03-02 | Gaspar Bobby (See Remarks) | Sale | 4,921 | 13.00 | 63,973 |
| 2020-03-02 | Gaspar Bobby (See Remarks) | Option Ex | 4,921 | .00 | 0 |
| 2020-01-02 | Fmr Llc (Other) | Sale | 28,474 | 13.48 | 383,829 |
Insider trading activities including stock purchases, stock sales, and option exercises of ORTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Orchard Therapeutics Plc (symbol ORTX, CIK number 1748907) see the Securities and Exchange Commission (SEC) website.